Marij Pharmaceuticals, Inc. (“MariJ” or the “Company”), a wholly-owned subsidiary of Acacia Diversified Holdings, Inc. (“Acacia”) (OTCQB symbol: ACCA), begins manufacturing USDA Certified Organic hemp oil.

Clearwater, Florida, Dec. 29, 2016 --

MariJ, a certified organic mobile CO2 processor and handler, has entered into a processing agreement with a certified organic hemp farm in Colorado, allowing our Company to produce what we believe to be some of the first, certified CO2 organic hemp oil to be manufactured in the United States..  

We also have obtained substantial information about a wide range of hemp crop issues this season, after the loss of a San Luis Valley Provider Agreement contract, which was to begin this past fall.  

Canna-Cures Research and Development, Inc. (“Canna-Cures”), also an Acacia subsidiary, is continuing the development of new and exciting Endocannabinoid Nutraceuticals products that have been added to the lineup. Canna-Cures does not treat patients, but rather, manufactures supplements for sale and distribution to those unaffiliated persons and entities who directly treat patients.

MariJ and Canna-Cures will continue to work closely together in 2017, to create new and innovative products while building synergistic business relationships within our industry.

After the results of the November election, there are 8 additional states that have passed new laws allowing activity in the cannabis industry. We believe that our Companies are well positioned, to assist our growers with our mobile CO2 extraction process, manufacturing and private labeling new and exciting products for them to take to market.

Forward-Looking Statements

Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Acacia or MariJ Pharmaceuticals websites does not constitute a part of this release.

Mr. Richard K. Pertile, CEO
MariJ Pharmaceuticals, Inc.
(an Acacia Diversified Holdings, Inc. Company)
13575 58th Street North - #138 
Clearwater, FL 33760
Email:  [email protected]
Internet:  http://www.marijinc.com/
Office:  (727) 678-4420   Fax:  (877) 513-6295